NeuroScientific Biopharmaceuticals Limited (NSB.AX)
AUD 0.04
(5.71%)
AUD 0.04
(5.71%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -91.33 Thousand AUD | -101.87% |
| 2023 | 4.89 Million AUD | 7640.79% |
| 2022 | -64.91 Thousand AUD | -107.23% |
| 2021 | 897.36 Thousand AUD | 1683.74% |
| 2020 | -56.66 Thousand AUD | -165.32% |
| 2019 | -21.35 Thousand AUD | -51.39% |
| 2018 | -14.1 Thousand AUD | -150.14% |
| 2017 | 28.13 Thousand AUD | -75.75% |
| 2016 | 116 Thousand AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -42.43 Thousand AUD | 0.0% |
| 2024 Q4 | -48.9 Thousand AUD | 0.0% |
| 2024 FY | -91.33 Thousand AUD | -101.87% |
| 2023 Q4 | 3.76 Million AUD | 0.0% |
| 2023 FY | 4.89 Million AUD | 7640.79% |
| 2023 Q2 | 1.12 Million AUD | 0.0% |
| 2022 Q2 | -31.9 Thousand AUD | 0.0% |
| 2022 FY | -64.91 Thousand AUD | -107.23% |
| 2022 Q4 | -33.01 Thousand AUD | 0.0% |
| 2021 FY | 897.36 Thousand AUD | 1683.74% |
| 2021 Q2 | -29.34 Thousand AUD | 0.0% |
| 2021 Q4 | 926.7 Thousand AUD | 0.0% |
| 2020 Q4 | -28.35 Thousand AUD | 0.0% |
| 2020 FY | -56.66 Thousand AUD | -165.32% |
| 2020 Q2 | -28.31 Thousand AUD | 0.0% |
| 2019 Q4 | 5492.00 AUD | 0.0% |
| 2019 Q2 | -5197.00 AUD | 0.0% |
| 2019 FY | -21.35 Thousand AUD | -51.39% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | -14.1 Thousand AUD | -150.14% |
| 2018 Q4 | -12.95 Thousand AUD | 0.0% |
| 2017 FY | 28.13 Thousand AUD | -75.75% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | 21.49 Thousand AUD | 0.0% |
| 2017 Q1 | - AUD | 0.0% |
| 2016 FY | 116 Thousand AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 87.804% |
| BTC Health Limited | 16.36 Thousand AUD | 658.295% |
| CSL Limited | 15.28 Billion AUD | 100.001% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 100.794% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 100.117% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 107.298% |
| Orthocell Limited | 3.68 Million AUD | 102.476% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 91.868% |
| Race Oncology Limited | 1.38 Million AUD | 106.571% |
| Starpharma Holdings Limited | 7.65 Million AUD | 101.193% |
| AdAlta Limited | 1.5 Million AUD | 106.057% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | 988.147% |
| Memphasys Limited | 1606.00 AUD | 5787.235% |
| Acrux Limited | -1.28 Million AUD | 92.887% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 69.701% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 98.606% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 103.944% |
| Nyrada Inc. | -5164.07 AUD | -1668.702% |
| PharmAust Limited | -1641.00 AUD | -5465.935% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 99.571% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | -251.58% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 102.4% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 102.277% |
| Biome Australia Limited | 7.66 Million AUD | 101.191% |
| Biotron Limited | -40.49 Thousand AUD | -125.535% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 101.225% |
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 100.179% |
| Immutep Limited | 1.44 Million AUD | 106.326% |
| Imugene Limited | -5.83 Million AUD | 98.436% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 107.534% |
| Noxopharm Limited | -534.81 Thousand AUD | 82.922% |
| Patrys Limited | 1.39 Million AUD | 106.551% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 102.46% |
| PYC Therapeutics Limited | 22.05 Million AUD | 100.414% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 100.03% |
| Dimerix Limited | 583.47 Thousand AUD | 115.654% |
| Hexima Limited | - AUD | Infinity% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 100.045% |
| Nanollose Limited | -348.95 Thousand AUD | 73.825% |
| Tissue Repair Ltd | 150.51 Thousand AUD | 160.685% |
| AnteoTech Limited | 460.39 Thousand AUD | 119.839% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 260.771% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 75.097% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | -108.556% |
| Actinogen Medical Limited | 9.93 Million AUD | 100.92% |
| Immuron Limited | 3.33 Million AUD | 102.737% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 103.516% |